Trial Profile
A Phase I Trial of Irinotecan and BKM120 in Previously Treated Advanced Colorectal Cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Buparlisib (Primary) ; Irinotecan
- Indications Adenocarcinoma; Colorectal cancer
- Focus Adverse reactions
- 01 Dec 2015 Planned End Date changed from 1 Dec 2015 to 1 Jan 2016 as reported by ClinicalTrials.gov.
- 31 Mar 2015 Planned End Date changed from 1 Mar 2015 to 1 Dec 2015, as reported by ClinicalTrials.gov.
- 31 Mar 2015 Planned primary completion date changed from 1 Dec 2014 to 1 Jun 2015, as reported by ClinicalTrials.gov.